Main content

Marvellous medicine

Have we learned how to permanently accelerate drug development?

Most of us were blindsided by the novel virus SarsCov2, but infectious disease experts had been warning about the possibility of a global pandemic for years. For them it was never a matter of if, but when. What did come as a surprise was the speed of scientific progress to fight Covid 19. The first effective vaccine, from Pfizer/BioNTech, was developed in under 300 days, followed in successive weeks by Moderna and Oxford/AstraZeneca. The results of the UK’s RECOVERY trial, which was organised in a matter of weeks, has saved an estimated million lives worldwide by identifying which treatments are effective in treating Covid-19.

During the pandemic, the world witnessed how fast medicine can advance with an abundance of cash and collaboration. Is progress at this speed and cost sustainable?

Sandra Kanthal asks if drug development is something which should still take decades, or have we learned how to permanently accelerate the process?

(Photo: Covid-19 vaccine vials on dry ice illustration. Dado Ruvic/Reuters)

Available now

23 minutes

Last on

Mon 28 Jun 2021 02:06GMT

Broadcasts

  • Sat 26 Jun 2021 19:06GMT
  • Sun 27 Jun 2021 09:06GMT
  • Sun 27 Jun 2021 21:06GMT
  • Mon 28 Jun 2021 02:06GMT